- Abexinostat,
Pharmacyclics'
primary commercial product. In
March 2015, Chicago-based
biopharmaceutical firm
AbbVie announced it
would acquire Pharmacyclics, as...
- of
Pharmacyclics to
AbbVie in "one of the
biggest paydays ever from the
buyout of a
publicly held company." As CEO and
chairman of
Pharmacyclics from...
-
Johnson and
Pharmacyclics agreed to co-develop the drug, and J&J paid
Pharmacyclics $150
million upfront and $825
million in milestones.
Pharmacyclics was acquired...
-
oncology firm
Pharmacyclics and its
treatment for
blood cancers, ibrutinib;
AstraZeneca had also been
bidding to
acquire Pharmacyclics.
Under the terms...
- of
Pharmacyclics, Inc., a
company that
works with
expanded porphyrins, and Anionics, Inc.,
which develops anion recognition chemistry.
Pharmacyclics was...
- 1517/14656566.8.3.351. PMID 17266469. S2CID 25542776.
Pharmacyclics, Inc.
press release -
Pharmacyclics to
Submit New Drug
Application for
Xcytrin for Treatment...
-
Antrin by
Pharmacyclics Inc. It is a
photosensitiser for use in
photodynamic therapy to
treat skin
conditions and
Prostate cancer.
Pharmacyclics and the...
-
manufacture two
biologic drugs.
Lonza also
manufactures Imbruvica for
Pharmacyclics and
Mydicar for Celladon. In 2015,
Lonza contracted with
Alexion to...
-
MarkWest Energy Partners's $21
Billion Merger with MPLX. "AbbVie to Buy
Pharmacyclics in $21
Billion Deal". Wall
Street Journal. 5
March 2015. "Coffee meets...
-
MACROGENICS (USA, 2011/12),
GALAPAGOS (NDL, 2011),
BIOREALITES (FR, 2011),
PHARMACYCLICS - HDAC
inhibitor (USA, 2009),
HYBRIGENICS (FR, 2007/2011)
VERNALIS (UK...
